Revlimid has been found to lengthen the lives of patients with multiple myeloma, a deadly bone cancer, by up to three years
Link to ArticleCharities lobby Nice over cancer drug - The Guardian 29th October 2008
Thursday, October 30, 2008
Posted by Kieran at 9:29 am
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment